Stellate Plasmonic Exosomes for Penetrative Targeting Tumor NIR-II Thermo-Radiotherapy

Abstract

Multifunctional gold (Au)-based nanomaterials with high atomic number (symbol Z) and strong absorbance in the second near-infrared window (NIR-II) property are emerging as promising candidates for tumor thermo-radiotherapy. The main limitations of applying Au-based nanomaterials to biomedical studies include the absence of active tumor-targeting ability, penetrating efficiency, and stability. In this study, we present a novel type of tumor cell-derived stellate plasmonic exosomes (TDSP-Exos) for penetrative targeted tumor NIR-II thermo-radiotherapy and photoacoustic imaging. The TDSP-Exos are abundantly and easily produced by the incubation of tumor cells with gold nanostars, based on which gold nanostars promote the exocytosis of exosomes from tumor cells. Compared with bare gold nanostars, the TDSP-Exos exhibit pronounced accumulation in deep tumor tissues and perform well in both PA imaging and NIR-II thermo-radiotherapy against the tumor. Moreover, the TDSP-Exos improve tumor hypoxia to enhanced radiotherapy by NIR-II photothermal therapy. This work indicates that the tumor cell-derived exosomes have the potential to function as a universal carrier of photothermal agents for targeted tumor NIR-II thermo-radiotherapy.

A platelet-mimicking theranostic platform for cancer interstitial brachytherapy

“…For this reason, BT optimizes the therapeutic effects in tumors while avoiding systemic radiotoxicity to normal organs and alleviating the suffering of patients 18 . BT is recommended for the treatment of prostate cancer 19 , 20 , cervical cancer 21 , and other types of cancers 22 , 23 .…”

“…Various approaches have been devised to either alleviate or leverage such intratumoral hypoxia 20 - 22 . Magnetic hyperthermia and photothermal therapy approaches increase the intra-tumoral temperature and blood flow, thus improving oxygen delivery to the tumor site 23 - 25 . Tirapazamine, in contrast, is a prodrug that is activated under hypoxic conditions and can be administered as a complementary approach together with radiotherapy to treat hypoxic tumors 26 , 27 .…”

Injectable Hydrogel for Cu2+ Controlled Release and Potent Tumor Therapy

“…An effective advancement has been made in the detection and cure of carcinoma, however, cancer is a lethal disease across the globe [ 1 , 2 , 3 , 4 , 5 ], and chemotherapy is still frequently used for the treatment of carcinoma in the clinical field [ 3 , 6 , 7 , 8 , 9 ], although it has adverse and harmful side effects, i.e., multidrug resistance [ 10 , 11 , 12 , 13 , 14 , 15 ]. Therefore, it is needed to find out new effective drugs against carcinoma with relatively fewer side effects.…”

An Injectable Hydrogel for Enhanced FeGA-Based Chemodynamic Therapy by Increasing Intracellular Acidity

“…Cancer, as one of the primary diseases affecting human health, has a profound impact on human life, and the patient's condition becomes due to the rapid propagation and diffusion of cancer cells, and the lower efficacy of the currently used chemotherapeutic agents (1)(2)(3)(4)(5). However, cancer cells are very sensitive to reactive oxygen species (ROS), increased ROS levels can cause cell redox imbalance, thus resulting in permanent damage to the orgate and, eventually, apoptosis (6,7).…”